Detalles de la búsqueda
1.
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
Clin Infect Dis
; 69(9): 1509-1516, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30629148
2.
Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
BMC Infect Dis
; 18(1): 500, 2018 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285653
3.
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
Infect Immun
; 85(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27895131
4.
Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.
Appl Microbiol Biotechnol
; 101(1): 381-390, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27796441
5.
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains.
Infect Immun
; 83(10): 3771-80, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26169272
6.
Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion.
Infect Immun
; 79(9): 3492-500, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21690242
7.
Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen.
NPJ Vaccines
; 6(1): 49, 2021 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33824336
8.
Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.
Vet Parasitol
; 160(3-4): 215-20, 2009 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-19059724
9.
TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25.
JCI Insight
; 3(10)2018 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29769448
10.
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.
PLoS One
; 12(9): e0185606, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28957391
11.
Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate.
Sci Rep
; 7: 40312, 2017 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28091576
12.
A defined subunit vaccine that protects against vector-borne visceral leishmaniasis.
NPJ Vaccines
; 2: 23, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29263878
13.
Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
Vaccine
; 34(44): 5225-5234, 2016 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27665354
14.
Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen.
Vaccine
; 34(19): 2207-15, 2016 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994314
15.
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.
Vaccine
; 34(25): 2779-86, 2016 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27142329
16.
Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan.
Trans R Soc Trop Med Hyg
; 109(9): 594-600, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26246251
17.
Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients.
Am J Trop Med Hyg
; 91(6): 1109-15, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25311696
18.
Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells.
Vaccine
; 30(28): 4216-24, 2012 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22542815
19.
KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi.
PLoS Negl Trop Dis
; 6(4): e1610, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22509423
20.
Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice.
Vaccine
; 30(22): 3311-9, 2012 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22425788